Where Can I Get TRT? A Guide to Safe, Legal Options

At a glance
- Diagnosis threshold / total testosterone below 300 ng/dL on two separate morning draws (Endocrine Society 2018)
- Prescription required / testosterone is a Schedule III controlled substance in the U.S.
- Provider types / urologists, endocrinologists, primary care physicians, telehealth clinics
- Common formulations / injectable cypionate, topical gels (AndroGel, Testim), nasal (Natesto), oral (Jatenzo)
- Typical cost without insurance / $30 to $500 per month depending on formulation
- Lab monitoring frequency / every 6 to 12 months once stable (hematocrit, PSA, lipids, testosterone trough)
- Telehealth legality / permitted in all 50 states for TRT prescribing as of 2026
- Average time to symptom improvement / energy and mood within 3 to 6 weeks, body composition changes by 12 to 16 weeks
Who Can Prescribe TRT?
Any physician with an active DEA registration and state medical license can prescribe testosterone. The three most common provider pathways are specialists, primary care doctors, and telehealth platforms, and each has distinct advantages depending on your situation, insurance coverage, and geographic access.
Urologists and Endocrinologists
Urologists manage male reproductive and hormonal health as a core competency. If you have concerns about fertility preservation while on TRT, a urologist can co-prescribe medications like human chorionic gonadotropin (hCG) or enclomiphene to maintain spermatogenesis [1]. Endocrinologists specialize in the full hormonal axis and are the best fit if you suspect a pituitary or hypothalamic cause for low testosterone. Wait times for specialist appointments can run 4 to 12 weeks depending on metro area.
Primary Care Physicians
Your family doctor or internist can diagnose and treat hypogonadism. The Endocrine Society's 2018 clinical practice guideline recommends that any clinician comfortable with the monitoring protocol can manage TRT long-term [1]. This is often the fastest path to treatment if you already have an established patient relationship. Ask your PCP directly. Many will order the initial labs (total testosterone, free testosterone, LH, FSH, CBC, metabolic panel) during a routine visit.
Telehealth Men's Health Clinics
Online platforms now offer end-to-end TRT management: lab orders, video consultations, prescription fulfillment, and ongoing monitoring. Telehealth is legal for controlled substance prescribing in all 50 U.S. States following the DEA's 2025 telemedicine rule updates, though specific requirements vary by state [2]. Telehealth visits typically cost $99 to $199 for an initial consultation and $50 to $150 per month for ongoing care. Prescriptions ship from licensed pharmacies (retail or compounding) directly to your door.
How Do You Get Diagnosed?
A TRT prescription requires a clinical diagnosis of hypogonadism, not just a single low lab value. The diagnostic process follows a specific sequence that protects you from unnecessary treatment and catches underlying conditions that could be causing your symptoms.
The Two-Draw Rule
The Endocrine Society guideline mandates at least two morning fasting total testosterone measurements below 300 ng/dL, drawn between 7:00 and 10:00 AM when testosterone peaks [1]. A single low reading is not sufficient. Acute illness, poor sleep, opioid use, and obesity can all transiently suppress testosterone. The American Urological Association (AUA) uses a similar threshold of 300 ng/dL but emphasizes that the diagnosis also requires signs or symptoms of deficiency [3].
Symptoms That Support Diagnosis
Documented symptoms strengthen the clinical case. Common complaints include reduced libido, erectile dysfunction, fatigue, depressed mood, decreased muscle mass, and increased body fat. The AUA Hypogonadism Guideline Panel noted that "testosterone therapy should be offered to men with symptomatic testosterone deficiency to induce and maintain secondary sex characteristics and to improve sexual function, sense of well-being, and bone mineral density" [3].
Additional Workup
Before starting TRT, your provider should check LH and FSH levels to distinguish primary hypogonadism (testicular failure) from secondary hypogonadism (pituitary or hypothalamic dysfunction). A prolactin level rules out prolactinoma. A complete blood count (CBC) establishes your baseline hematocrit, since testosterone stimulates erythropoiesis and can push hematocrit above safe thresholds [4]. PSA and a digital rectal exam are recommended for men over 40 before initiating therapy [1].
What Are the Legal TRT Formulations?
The FDA has approved several testosterone delivery systems, each with different pharmacokinetics, convenience profiles, and costs. All require a prescription. None are available over the counter in the United States.
Injectable Testosterone
Testosterone cypionate and testosterone enanthate are the most widely prescribed formulations. Cypionate is typically dosed at 100 to 200 mg intramuscularly every 7 to 14 days, or 50 to 80 mg subcutaneously twice weekly for more stable serum levels [5]. Generic cypionate costs $30 to $60 per month, making it the most affordable option. The FDA-approved auto-injector Xyosted (subcutaneous testosterone enanthate) runs approximately $500 per month without insurance but offers dosing convenience.
Topical Gels and Solutions
AndroGel (1% and 1.62%), Testim, and Vogelxo deliver testosterone transdermally. They produce steady-state serum levels within 2 to 4 days of consistent application. The primary concern is transference risk: skin-to-skin contact can expose partners or children to testosterone [6]. The FDA's boxed warning on gel products specifically addresses secondary exposure in children, which has caused virilization in reported cases [6]. Generic gel formulations cost $50 to $150 per month. Brand-name products without insurance can exceed $500.
Oral and Nasal Options
Jatenzo (testosterone undecanoate capsules) bypasses hepatic first-pass metabolism through lymphatic absorption, avoiding the liver toxicity associated with older oral androgens like methyltestosterone [7]. It requires twice-daily dosing with food. Natesto, a nasal gel applied three times daily, delivers testosterone through the nasal mucosa and may suppress the hypothalamic-pituitary-gonadal axis less than injectable or transdermal formulations, which could be relevant for fertility preservation [8].
Pellet Implants
Testopel consists of crystalline testosterone pellets implanted subcutaneously in the hip or buttock every 3 to 6 months. The procedure takes about 10 minutes in-office. Pellets provide consistent release without daily or weekly dosing. Cost ranges from $500 to $900 per insertion, and some patients report pellet extrusion (reported in approximately 5% to 10% of insertions) [9].
How Much Does TRT Cost?
Cost varies dramatically by formulation, pharmacy type, and insurance coverage. Generic testosterone cypionate at a retail pharmacy with a GoodRx-style coupon may cost as little as $25 to $40 for a 10 mL vial (a 10- to 20-week supply). Brand-name products like AndroGel 1.62% carry a list price above $600 per month.
Insurance Coverage
Most commercial insurance plans and Medicare Part D cover testosterone cypionate and generic topical gels when prescribed for a documented diagnosis of hypogonadism (ICD-10 E29.1). Prior authorization is common and typically requires two low testosterone lab values plus symptom documentation [10]. Plans may restrict coverage to generic formulations and require step therapy (trying generics before brand-name products).
Compounding Pharmacies
Compounding pharmacies can prepare testosterone cypionate in custom concentrations and carrier oils (e.g., grapeseed oil for patients with cottonseed oil sensitivity). Compounded testosterone typically costs $40 to $100 per month. The pharmacy must hold a valid state compounding license, and if shipping across state lines, should be accredited by the Pharmacy Compounding Accreditation Board (PCAB) or registered as a 503B outsourcing facility with the FDA [11].
What to Watch Out For
Any source selling testosterone without requiring a prescription is operating illegally. "Research chemical" testosterone, gray-market imports, and underground labs carry real risks: contamination, incorrect concentrations, and legal consequences. Possession of a Schedule III controlled substance without a prescription is a federal offense [12].
What Does Ongoing Monitoring Look Like?
TRT is not a one-time prescription. Safe therapy requires regular blood work and clinical follow-up to catch complications early and optimize your dose.
First-Year Monitoring Schedule
The Endocrine Society recommends checking serum testosterone, hematocrit, and PSA at 3 months, 6 months, and 12 months after starting TRT [1]. The target trough testosterone level (measured at the lowest point in your dosing cycle) is 400 to 700 ng/dL for most men. If hematocrit exceeds 54%, the guideline recommends dose reduction, switching to a shorter-acting formulation, therapeutic phlebotomy, or temporary discontinuation [1].
Long-Term Surveillance
After the first year, labs every 6 to 12 months are standard. A lipid panel and metabolic panel should be checked annually. Bone density testing (DEXA scan) is recommended at 1 to 2 years for men who started TRT with osteoporosis or osteopenia [1]. PSA monitoring continues annually for men over 40.
When to Involve a Specialist
A hematocrit that stays above 52% despite dose adjustments warrants a hematology referral. PSA velocity greater than 0.75 ng/mL per year or an absolute PSA above 4.0 ng/mL should prompt urology referral and possible prostate biopsy [1]. New or worsening sleep apnea symptoms require a sleep study, as testosterone can worsen obstructive sleep apnea in susceptible patients [13].
What About Fertility?
Exogenous testosterone suppresses gonadotropins (LH and FSH), which shuts down intratesticular testosterone production and spermatogenesis. Sperm counts can drop to zero within 3 to 6 months of starting TRT. A study published in the Journal of Clinical Endocrinology & Metabolism found that 65% of men on TRT became azoospermic by 6 months [14].
Fertility-Preserving Alternatives
If you want to maintain fertility while treating hypogonadism, your provider may prescribe clomiphene citrate (off-label, 25 to 50 mg daily), enclomiphene, or hCG (typically 1,500 to 3,000 IU two to three times per week) instead of or alongside a reduced dose of testosterone [15]. These agents stimulate endogenous testosterone production through the pituitary rather than replacing it directly.
Reversibility After Stopping TRT
Spermatogenesis recovery after discontinuing TRT takes a median of 6 to 12 months in most studies, though some men require longer. A retrospective analysis in Fertility and Sterility reported that 67% of men recovered sperm in the ejaculate within 6 months and 90% within 12 months of stopping testosterone [16]. Pre-treatment semen cryopreservation is recommended for any man who wants to keep the option of biological fatherhood open.
Telehealth vs. In-Person Clinics: How to Choose
Both models deliver the same medications from the same pharmacies. The difference is access, cost structure, and the depth of the initial physical exam.
Advantages of Telehealth
Telehealth eliminates geographic barriers. Men in rural areas or states with few endocrinologists can access board-certified providers within days rather than weeks. Lab work is done at a local Quest Diagnostics or Labcorp draw site. Medications ship to your door. Monthly subscription models bundle consultations, labs, and prescriptions into a predictable cost.
Advantages of In-Person Care
A hands-on physical exam can detect testicular atrophy, varicocele, gynecomastia, or prostate abnormalities that a video visit cannot. If your provider suspects a pituitary tumor based on lab work (elevated prolactin, very low LH and FSH), an in-person specialist can coordinate imaging and neurosurgery referral more efficiently. Insurance-based in-person visits may also carry lower out-of-pocket costs if you have a low copay.
Red Flags in Any Setting
Avoid any clinic that prescribes TRT without lab confirmation of low testosterone. Avoid providers who guarantee specific outcomes, sell proprietary "testosterone boosters" alongside prescriptions, or pressure you into high-cost pellet insertions without discussing injectable alternatives first. The AUA guideline explicitly states that TRT should not be initiated to improve fertility, athletic performance, or for age-related declines in testosterone without symptomatic hypogonadism [3].
Is TRT Legal Everywhere in the U.S.?
Testosterone with a valid prescription is legal in all 50 states, the District of Columbia, and U.S. Territories. It is classified as a Schedule III controlled substance under the Controlled Substances Act, which means prescribing, dispensing, and possession are regulated but permitted with proper medical authorization [12].
State-Level Variations
Some states impose additional requirements. A few states require an in-person visit before the first controlled substance prescription, though the majority now accept telemedicine encounters following the DEA's updated telemedicine prescribing policies [2]. Check your state medical board's current stance if you plan to use a telehealth platform based in a different state.
International Considerations
TRT legality varies widely outside the U.S. Testosterone is prescription-only in the UK, Canada, and Australia, with broadly similar prescribing standards. In some countries, testosterone products are available over the counter or through less regulated channels, but importing controlled substances into the U.S. Without a prescription violates federal law regardless of the source country's regulations.
Frequently asked questions
›Where can I get TRT?
›Can I get TRT online?
›How much does TRT cost without insurance?
›Does insurance cover TRT?
›What blood tests do I need before starting TRT?
›Will TRT affect my fertility?
›Is it legal to buy testosterone without a prescription?
›How long does it take for TRT to work?
›What are the risks of TRT?
›Can my primary care doctor prescribe TRT?
›What is the difference between testosterone cypionate and enanthate?
›Should I use a compounding pharmacy for TRT?
References
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://academic.oup.com/jcem/article/103/5/1715/4939465
- U.S. Drug Enforcement Administration. Telemedicine prescribing of controlled substances. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29366754/
- Bachman E, Travison TG, Basaria S, et al. Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin. J Clin Endocrinol Metab. 2014;99(10):3914-3920. https://pubmed.ncbi.nlm.nih.gov/25322269/
- Al-Futaisi AM, Al-Zakwani IS, Alnahdi HA, et al. Subcutaneous administration of testosterone: a pilot study report. Sultan Qaboos Univ Med J. 2006;6(1):69-72. https://pubmed.ncbi.nlm.nih.gov/21748132/
- U.S. Food and Drug Administration. Testosterone gel products safety communication. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/testosterone-gel-products-safety-communication-testosterone-gel-products
- Yin A, Swerdloff RS, He J, et al. Oral testosterone undecanoate: pharmacokinetic and pharmacodynamic study. J Clin Endocrinol Metab. 2012;97(10):3476-3484. https://pubmed.ncbi.nlm.nih.gov/22791756/
- Rogol AD, Tkachenko N, Badorrek P, et al. Phase I/II study of natesto nasal testosterone gel: effects on spermatogenesis. J Urol. 2016;195(4S):e1018. https://pubmed.ncbi.nlm.nih.gov/27105459/
- McCullough AR, Khera M, Goldstein I, et al. A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel) insertion. J Sex Med. 2012;9(2):594-601. https://pubmed.ncbi.nlm.nih.gov/22240267/
- Baillargeon J, Urban RJ, Ottenbacher KJ, et al. Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med. 2013;173(15):1465-1466. https://pubmed.ncbi.nlm.nih.gov/23939517/
- U.S. Food and Drug Administration. Human drug compounding. https://www.fda.gov/drugs/human-drug-compounding
- U.S. Drug Enforcement Administration. Controlled substance schedules. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due
- Hoyos CM, Killick R, Yee BJ, et al. Effects of testosterone therapy on sleep and breathing in obese men with severe obstructive sleep apnoea. Clin Endocrinol. 2012;77(4):599-607. https://pubmed.ncbi.nlm.nih.gov/22512435/
- Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility. Lancet. 1990;336(8721):955-959. https://pubmed.ncbi.nlm.nih.gov/1977002/
- Wheeler KM, Sharma D, Kavoussi PK, et al. Clomiphene citrate for the treatment of hypogonadism. Sex Med Rev. 2019;7(2):272-276. https://pubmed.ncbi.nlm.nih.gov/30770312/
- Kohn TP, Louis MR, Pickett SM, et al. Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy. Fertil Steril. 2017;107(2):351-357.e1. https://pubmed.ncbi.nlm.nih.gov/27916205/